🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: To determine maximum tolerated dose of farnesyl transferase in...
Status
Completed
Location
Duke University Health System
Start Date
2005-10
Trial ID
NCT00612651
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
The primary objective is to evaluate the intratumoral and plasma pharmacoki...
Status
Completed
Location
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
Start Date
2009-11
Trial ID
NCT00979173
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Duke Cancer Institute
Start Date
2005-05
Trial ID
NCT00354913
Treatments Being Tested
This is a phase II study of the combination of panitumumab with irinotecan ...
Status
Terminated
Location
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
Start Date
2010-02
Trial ID
NCT01017653
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2006-04
Trial ID
NCT00352521
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of cediran...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2008-04
Trial ID
NCT00662506
Treatments Being Tested
Most pediatric patients with solid tumors respond to initial high-dose, int...
Status
Recruiting
Location
Miller Children's and Women's Hospital Long Beach
Start Date
2014-07
Trial ID
NCT02446431
Treatments Being Tested
This is a study to determine the safety and efficacy of the drug, mebendazo...
Status
Active Not Recruiting
Location
Cohen Children's Medical Center of New York
Start Date
2013-10-22
Trial ID
NCT01837862
Treatments Being Tested
The primary objective of the study is to determine the efficacy of Avastin ...
Status
Completed
Location
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
Start Date
2009-11
Trial ID
NCT00979017
Treatments Being Tested